Recent Posts

RSS Financial News

Advertisments


Archive for April, 2007

The Emergence Of Islamic Finance As A Major Force In The World Financial System Has Focused Attention On Regulatory Issues

Wednesday, April 25th, 2007

Research and Markets (http://www.researchandmarkets.com/reports/c54999) has announced the addition of “Islamic Finance: The Regulatory Challenge” to their offering.
“Islamic Finance: The Regulatory Challenge…is therefore timely and a truly welcome addition to the growing literature on this subject…I congratulate the two professors for their fine contribution to the evolving art and science of the regulation of Islamic finance.”–Dr. […]

Online Channel Protection from MarkMonitor Boasts Direct Interface to eBay VeRO Program

Tuesday, April 24th, 2007

MarkMonitor®, the global leader in enterprise brand protection, today announced that Online Channel Protection™ from MarkMonitor is the first brand protection solution to provide a direct reporting interface to eBay Inc.’s (eBay) Verified Rights Owner (VeRO) program. This direct interface offers real-time reporting of copyright and trademark infringement including counterfeit protection for brand owners. The […]

REVShare Emerges as Successful Alternative to eBays Television Spot Trade System for Scatter Market

Tuesday, April 24th, 2007

REVShare’s time-tested TV advertising model solves recent challenges of automated spot trading while satisfying both the needs of advertisers and media. The hybrid model incorporates direct response (DRTV), cost-per-action (CPA), and traditional audience measurement. REVShare’s technology, CPA Metrics™, provides advertisers with impressions and rating points equivalency, as well as daypart and DMA delivery of CPA […]

AstraZeneca to Purchase MedImmune for $15.2 Billion

Monday, April 23rd, 2007

AstraZeneca Plc, struggling to develop new medicines, agreed to buy U.S. biotechnology company MedImmune Inc. for $15.2 billion in cash to gain flu vaccines and an antiviral treatment for babies.
Investors in MedImmune will get $58 a share, AstraZeneca said today. That’s 21 percent more than MedImmune’s April 20 closing price of $48.01. MedImmune, based in […]

Alliance Boots auction

Monday, April 23rd, 2007

The auction for Alliance Boots could have further to run. Terra Firma believes it will be able to submit a firm £10.9bn ($21.8bn) offer but will then face a higher counterbid from Kohlberg Kravis Roberts, its rival private equity s
Competing bids from a consortium of KKR and Stefano Pessina, executive deputy chairman of Alliance Boots, […]